
Sign up to save your podcasts
Or


Now that long-acting muscarinic receptor antagonists (LAMAs) have entered the scene, Dr. Tom Corbridge is joined by Dr. Navitha Ramesh, a pulmonologist and critical care physician at UPMC, to review some patient cases demonstrating how LAMAs may be changing the way we approach step-up treatment for some patients with asthma.
A non-promotional, non-CME educational program brought to you by CHEST in collaboration with GlaxoSmithKline.
There are numerous factors that contribute to an overall wellness of patients with of NTM refractory MAC lung disease. Listen in as Megan Carreon, Assistant Professor with the Division of Respiratory Care at UT Health San Antonio, Texas, sits down with pulmonary nurse practitioner Amy Levinger from NYU Langone Health and Dr. Tim Aksamit, Associate Professor of Pulmonary and Critical Care Medicine at Mayo Clinic.
For more information and to access clinician & patient tools about NTM and MAC Lung Disease, click here to visit the CHEST Foundation NTM webpage.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
With uncontrolled asthma placing such a tremendous burden on our patients and our society, how can we use the latest treatment guidelines to help alleviate that burden? Dr. Matt Hegewald is here to talk about the new and emerging guideline-based treatments for uncontrolled asthma, like long-acting muscarinic antagonists.
A non-promotional, non-CME educational program brought to you by CHEST in collaboration with GlaxoSmithKline.
Now that long-acting muscarinic receptor antagonists (LAMAs) have entered the scene, Dr. Tom Corbridge is joined by Dr. Navitha Ramesh, a pulmonologist and critical care physician at UPMC, to review some patient cases demonstrating how LAMAs may be changing the way we approach step-up treatment for some patients with asthma.
A non-promotional, non-CME educational program brought to you by CHEST in collaboration with GlaxoSmithKline.
There are numerous factors that contribute to an overall wellness of patients with of NTM refractory MAC lung disease. Listen in as Megan Carreon, Assistant Professor with the Division of Respiratory Care at UT Health San Antonio, Texas, sits down with pulmonary nurse practitioner Amy Levinger from NYU Langone Health and Dr. Tim Aksamit, Associate Professor of Pulmonary and Critical Care Medicine at Mayo Clinic.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
There are numerous factors that contribute to an overall wellness of patients with of NTM refractory MAC lung disease. Listen in as Megan Carreon, Assistant Professor with the Division of Respiratory Care at UT Health San Antonio, Texas, sits down with pulmonary nurse practitioner Amy Levinger from NYU Langone Health and Dr. Tim Aksamit, Associate Professor of Pulmonary and Critical Care Medicine at Mayo Clinic.
For more information and to access clinician & patient tools about NTM and MAC Lung Disease, click here to visit the CHEST Foundation NTM webpage.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
Patients with severe asthma account for a higher percentage of asthma-related morbidity and 50% of asthma-related costs. Unfortunately, a fair amount of these patients are managed with oral corticosteroids, despite the warnings and adverse events. The discussion will focus on the challenges encountered with oral corticosteroids and approaches to consider to improve the care of severe asthma patients.
Listen in as Dr. Tom Corbridge and Dr. Gary Ferguson discuss the challenges physicians and patients face when there is an underreporting of COPD symptoms. Together, they’ll also explore the ways physicians can overcome these obstacles and give their patients the appropriate treatment.
This episode is supported in part by an unrestricted/independent medical educational grant from GlaxoSmithKline.
Coming from the 2019 annual CHEST conference in New Orleans, Dr. Nicola Hanania joins Dr. Neil Freedman to discuss the advances in the diagnosis and treatment of COPD as well as the updated GOLD guidelines that were covered at the conference.
Coming from the 2019 annual CHEST conference in New Orleans, Dr. Nicola Hanania joins Dr. Neil Freedman to discuss the advances in the diagnosis and treatment of COPD as well as the updated GOLD guidelines that were covered at the conference.
From the publisher's feed

58 Listeners